ÂÜÀòÂÒÂ×

Kate Wells is an experienced professional in program management and clinical operations within the biotechnology and pharmaceutical industries. Currently serving as Associate Director of Program Management at Turnstone Biologics since June 2022, Kate has previously held notable positions as Clinical Trial Lead at Bristol Myers Squibb and MyoKardia, where responsibilities included managing and overseeing clinical trials. Earlier roles include Clinical Trial Specialist and Clinical Trial Associate at Ultragenyx Pharmaceutical Inc. Kate holds a Bachelor of Science in Microbiology from UC Santa Barbara, obtained in 2015, and completed high school at Campolindo High School in 2011.